Anfarm Hellas S.A. - Main Component
Active Substance | Strength | Form |
---|---|---|
L-carnitine | 1g/10ml Vial | Oral.Sol |
Lacosamide | 10mg/ml | Sol.Inf |
Lacosamide | 10mg/ml | Oral Solution |
LetermovirUnder Development | 240&480mg/vial | C.So.In |
LetermovirUnder Development | 240&480mg/tab | F.C. tabs |
Levofloxacin | 5mg/ml (100ml Bottle) | Sol.Inf |
Linezolid | 2mg/ml (300ml Plastic Bag) | Sol.Inf |
Lisinopril | 20mg, 40mg | Tab |
Loratadine | 10mg | Tab |
Losartan Potassium | 100mg | F.C.Tab |
Active Substance | Strength | Form |
---|---|---|
L-carnitine | 1g/10ml Vial | Oral.Sol |
Lacosamide | 10mg/ml | Sol.Inf |
Lacosamide | 10mg/ml | Oral Solution |
LetermovirUnder Development | 240&480mg/vial | C.So.In |
LetermovirUnder Development | 240&480mg/tab | F.C. tabs |
Levofloxacin | 5mg/ml (100ml Bottle) | Sol.Inf |
Linezolid | 2mg/ml (300ml Plastic Bag) | Sol.Inf |
Lisinopril | 20mg, 40mg | Tab |
Loratadine | 10mg | Tab |
Losartan Potassium | 100mg | F.C.Tab |
Active Substance | Strength | Form | Market Availability |
---|---|---|---|
L-carnitine | 1g/10ml Vial | Oral.Sol | International |
Lacosamide | 10mg/ml | Sol.Inf | International |
Lacosamide | 10mg/ml | Oral Solution | International |
LetermovirUnder Development | 240&480mg/vial | C.So.In | TBC |
LetermovirUnder Development | 240&480mg/tab | F.C. tabs | TBC |
Levofloxacin | 5mg/ml (100ml Bottle) | Sol.Inf | International |
Linezolid | 2mg/ml (300ml Plastic Bag) | Sol.Inf | International |
Lisinopril | 20mg, 40mg | Tab | Selected Markets |
Loratadine | 10mg | Tab | Selected Markets |
Losartan Potassium | 100mg | F.C.Tab | Selected Markets |